Medication overuse headache in Spain

Cephalalgia

Volumn 28, Issue 11, 2008, Pages 1234-1236

  Pascual, J ^a   Mateos, V ^a   Gracia, M ^a   Lainez J M ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; CODEINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PROPIFENAZONE; UNCLASSIFIED DRUG;

DEMOGRAPHY; DRUG EFFICACY; DRUG TOLERABILITY; DRUG USE; HEADACHE; HUMAN; MIGRAINE; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; SHORT SURVEY; SPAIN; TENSION HEADACHE;

AGE DISTRIBUTION; FEMALE; HEADACHE DISORDERS, SECONDARY; HUMANS; MALE; PREVALENCE; SEX DISTRIBUTION; SPAIN;

EID: 53549119129     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2008.01730.x     Document Type: Short Survey

References (4)

1. Castillo J, Muñoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache 1999 39 : 190 6.
2. Colás R, Muñoz P, Temprano R, Gómez C, Pascual J. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 2004 62 : 1338 42.
3. Gracia-Naya M, Alarcia R, Modrego PJ. Importancia de la migraña crónica en una consulta general de neurología. Rev Neurol 2008 46 : 577 81.
4. Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología. Guías para el diagnóstico y tratamiento de las cefaleas, Mateos V, editor. Barcelona : Prous Science 2006.